Shares of Scilex Holding (NASDAQ:SCLXW – Get Free Report) rose 2% during trading on Wednesday . The company traded as high as $0.21 and last traded at $0.2090. 5,026 shares traded hands during mid-day trading, a decline of 8% from the average session volume of 5,488 shares. The stock had previously closed at $0.2049.
Scilex Price Performance
The firm’s fifty day moving average is $0.17 and its two-hundred day moving average is $0.15.
About Scilex
Scilex Holding Company is a specialty pharmaceutical firm focused on the commercialization, licensing and distribution of branded products for the management of acute and chronic pain. Established through a series of strategic acquisitions and internal development efforts, the company concentrates on non-opioid, topical and systemic therapies designed to address unmet needs in neuropathic and musculoskeletal pain. Scilex partners with healthcare providers, pharmacies and specialty distributors to bring its portfolio to patients across the United States.
The company’s flagship product, ZTlido® (lidocaine topical system 1.8%), is an FDA-approved prescription patch indicated for the relief of pain associated with postherpetic neuralgia.
See Also
- Five stocks we like better than Scilex
- Datadog’s Drop Says More About Expectations Than Earnings
- D-Wave’s Quantum Breakthrough Couldn’t Save QBTS From a Sell-Off
- Cloudflare’s Beat-and-Raise Quarter Puts Its AI Edge Story in Focus
- Solventum Nears Inflection Point As It Begins to Unlock Value
Receive News & Ratings for Scilex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Scilex and related companies with MarketBeat.com's FREE daily email newsletter.
